CAPUTI, Achille
 Distribuzione geografica
Continente #
NA - Nord America 11.641
EU - Europa 8.598
AS - Asia 1.934
SA - Sud America 17
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 9
AF - Africa 6
Totale 22.214
Nazione #
US - Stati Uniti d'America 11.603
IE - Irlanda 2.524
SE - Svezia 2.253
CN - Cina 1.731
UA - Ucraina 1.501
DE - Germania 931
FI - Finlandia 521
GB - Regno Unito 383
IT - Italia 186
IN - India 107
RU - Federazione Russa 73
PL - Polonia 41
BE - Belgio 39
FR - Francia 38
CA - Canada 31
IR - Iran 21
KR - Corea 19
CH - Svizzera 15
CZ - Repubblica Ceca 14
RO - Romania 14
CL - Cile 11
IL - Israele 11
AU - Australia 8
JP - Giappone 8
NL - Olanda 8
ES - Italia 7
EU - Europa 7
BG - Bulgaria 6
RS - Serbia 6
SG - Singapore 6
EE - Estonia 4
EG - Egitto 4
SA - Arabia Saudita 4
TR - Turchia 4
VN - Vietnam 4
AT - Austria 3
BD - Bangladesh 3
DK - Danimarca 3
HK - Hong Kong 3
HR - Croazia 3
HU - Ungheria 3
LI - Liechtenstein 3
LV - Lettonia 3
MX - Messico 3
PA - Panama 3
PT - Portogallo 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AR - Argentina 2
AZ - Azerbaigian 2
BR - Brasile 2
IM - Isola di Man 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LT - Lituania 2
LU - Lussemburgo 2
MD - Moldavia 2
MT - Malta 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
BO - Bolivia 1
IQ - Iraq 1
IS - Islanda 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MK - Macedonia 1
MM - Myanmar 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PR - Porto Rico 1
ZA - Sudafrica 1
Totale 22.214
Città #
Jacksonville 3.030
Dublin 2.523
Chandler 2.028
Nyköping 1.182
Beijing 648
Ashburn 505
Princeton 505
Cambridge 497
Dearborn 450
Des Moines 391
Medford 391
Boardman 369
Ann Arbor 237
Wilmington 177
Jinan 144
Woodbridge 143
Shenyang 121
Lancaster 112
Nanjing 85
Hebei 77
New York 73
Tianjin 69
Houston 67
San Mateo 66
Messina 64
Ningbo 63
Haikou 53
Hangzhou 53
Guangzhou 52
Zhengzhou 50
Seattle 48
Taizhou 47
Hyderabad 46
Los Angeles 40
Brussels 39
Pune 38
Nanchang 36
Helsinki 32
Falls Church 29
Washington 29
Warsaw 28
Jiaxing 27
Bremen 25
Fuzhou 25
Augusta 24
Changsha 24
Auburn Hills 23
Norwalk 22
Saint Petersburg 22
Lanzhou 20
Leawood 20
Ottawa 20
Taiyuan 20
Ardabil 17
Edinburgh 16
Miechow 13
Tappahannock 13
Frankfurt am Main 12
London 10
Monmouth Junction 10
Milan 9
Focsani 8
Brno 7
Catania 7
Mumbai 7
Riva 7
Amsterdam 6
Belgrade 6
Bern 6
Chicago 6
Leipzig 6
Sofia 6
Capua 5
Hefei 5
Kunming 5
Novokuznetsk 5
Puxian 5
Rome 5
Strasbourg 5
Sydney 5
Changle 4
Chengdu 4
Clearwater 4
Cusano Milanino 4
Dong Ket 4
Kemerovo 4
Las Vegas 4
Madrid 4
Milazzo 4
Nuremberg 4
Pace 4
Prague 4
Regensburg 4
San Vittore Olona 4
Stockholm 4
Tallinn 4
Tokyo 4
Toronto 4
Turin 4
Aarau 3
Totale 15.200
Nome #
Effectiveness and Safety of Switching Originator and Biosimilar Epoetins in Patients with Chronic Kidney Disease in a Large-Scale Italian Cohort Study 101
Trends in the prescription of antidiabetic medications from 2009 to 2012 in a general practice of Southern Italy: A population-based study 83
Allergic reactions to oral drugs: A case/non-case study from an Italian spontaneous reporting database (GIF). 82
PATTERN PRESCRITTIVO DI FARMACI ANTIEPILETTICI NELL'ANZIANO: STUDIO DI POPOLAZIONE IN UN'AREA DEL SUD ITALIA NEGLI ANNI 2004-2007 80
Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study 79
A NEW MELANOCORTIN AGONIST REDUCES CERULEIN INDUCED PANCREATIC DAMAGE IN AN EXPERIMENTAL RAT MODEL 78
Amoxicillin and amoxicillin plus clavulanate: a safety review 77
The tyrosine kinase inhibitor tyrphostin AG 126 reduces the multiple organ failure induced by zymosan in the rat 77
USO DI SERM ED INIBITORI DELL'AROMATASI IN PRATICA CLINICA: ANALISI DEL TREND PRESCRITTIVO SU UN UNA POPOLAZIONE DI MEDICINA GENERALE DEL SUD ITALIA 75
Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population 74
Effects of polydeoxyribonucleotide on the histological damage and the altered spermatogenesis induced by testicular ischaemia and reperfusion in rats 74
17 beta-estradiol antiinflammatory activity in carrageenan- induced pleurisy 73
Modeling and biological evaluation of 3.3 '-(1,2- ethanediyl)bis[2-(4-methoxyphenyl)-thiazolidin-4-one], a new synthetic cyclooxygenase-2 inhibitor 73
Effetti di una PGE2 sintetica sulle cellule caliciformi mucipare della congiuntiva del coniglio 73
Absence of endogenous interleukin-6 enhances the inflammatory response during acute pancreatitis induced by cerulein in mice 72
“Newer and older antiepileptic drug in southern Italy: a population based study during the years 2003-2005” 70
WY 14643, a potent exogenous PPAR-alpha ligand reduces intestinal injury associated with splanchnic artery occlusion (SAO) shock. 70
Focus: Linguistic, cognitive, and computational perspectives 70
Geometric models in classical thermomechanics of continua with applications to irreversible phenomena 70
Clinical minimal intervention in smoking cessation. 70
Absence of endogeneous interleukin-10 enhances the evolution of murine type-II collagen-induced arthritis 68
Inducible nitric oxide synthase mediates bone loss in ovariectomized mice 68
Inhibition of nuclear factor-kappa B activation by IRFI 042, protects against endotoxin-induced shock 68
WWW.FARMACOVIGILANZA.ORG: OBIETTIVI E RISULTATI 68
Calpain inhibitor I reduces colon injury caused by dinitrobenzene sulphonic acid in the rat 67
17 beta-oestradiol reduces cardiac leukocyte accumulation in myocardial ischaemia reperfusion injury in rat 67
Beneficial effects of rHuEPO administration in a transgenic mouse model of amyotrophic lateral sclerosis 66
ROSIGLITAZONE A LIGANDS OF THE PEROXISOME PROLIFERATOR-ACTRIVATED RECEPTOR-γ (PPAR-γ), REDUCE THE EVOLUTION OF MURINE TYPE II COLLAGEN-INDUCED ARTHRITIS 66
White cells count in smokers affected by rheumatic diseases 66
Expert opinion of nephrologists about the effectiveness of low-protein diet in different stages of chronic kidney disease (CKD) 65
Nitric oxide mediates vascular endothelial growth factor gene transfer effects on wound healing after experimental burn injury 65
The reduction of myocardial damage and leukocyte polymorphonuclear accumulation following coronary artery occlusion by the tyrosine kinase inhibitor tyrphostin AG 556 65
VASCULAR ENDOTHELIAL GROWTH FACTOR GENE TRANSFER STIMULATES ANGIOGENESIS AND WOUND HEALING IN THE GENETICALLY DIABETIC MOUSE 64
The tyrosine kinase inhibitor tyrphostin AG 126 reduces the development of colitis in the rat 64
G-619, A DUAL THROMBOXANE SYNTHASE INHIBITOR AND THROMBOXANE A(2) RECEPTOR ANTAGONIST, INHIBITS TUMOR-NECROSIS-FACTOR-ALPHA BIOSYNTHESIS 64
Effects of cloricromene on the levels of endothelin and on the microcirculatory function in peripheral atherosclerotic arteriopathies 64
Drug safety information through the internet: the experience of an Italian website. 64
ADENOSINE RECEPTOR STIMULATION BY POLYDEOXYRIBONUCLEOTIDE ACTIVATES CELL CYCLE AND IMPROVES SKIN HEALING IN THE GENETICALLY DIABETIC MOUSE. 64
Cardiovascular biomarkers in groups of established smokers after a decade of smoking 64
Oral administration of a soy extract improves endothelial dysfunction in ovariectomized rats 63
Role of induced nitric oxide in the initiation of the inflammatory response after postischemic injury 63
A role for superoxide in gentamicin-mediated nephropathy in rats 63
reduction in the evolution of murine type II collagen-induced arthritis by treatment with rosiglitazone, a ligand of the peroxisome proliferator-activated receptor gamma 63
A DECREASED BRAIN-STEM CONTENT OF GABA MEDIATES HYPERINSULINEMIA IN OBESE ZUCKER RATS 63
TCV-309, A NOVEL PLATELET-ACTIVATING-FACTOR ANTAGONIST, INHIBITS LEUKOCYTE ACCUMULATION AND PROTECTS AGAINST SPLANCHNIC ARTERY-OCCLUSION SHOCK 63
ANTIBODIES AGAINST INTERCELLULAR-ADHESION MOLECULE-1 PROTECT AGAINST MYOCARDIAL ISCHEMIA-REPERFUSION INJURY IN RAT 63
Cardioprotection by the phytoestrogen genistein in experimental myocardial ischaemia-reperfusion injury 63
Adverse drug reactions related to amoxicillin alone and in association with clavulanic acid: data from spontaneous reporting in Italy. 63
A protective effect of the synthetic coumarine derivative cloricromene on DNB-colitis in the rat. 63
Interactions Between Endocannabinoid and Serotonergic Systems in Mood Disorders Caused by Nicotine Withdrawal 63
Sugli effetti di un analogo stabile della PGE2 sulla secrezione lacrimale del coniglio 63
PROTECTIVE EFFECTS OF BAY-U-3405, A THROMBOXANE-A(2) RECEPTOR ANTAGONIST, IN ENDOTOXIN-SHOCK 62
Adrenocorticotropin reverses hemorrhagic shock in anesthetized rats through the rapid activation of a vagal anti-inflammatory pathway 62
Antioxidant activity of U-83836E, a second generation lazaroid, during myocardial ischemia/reperfusion injury 62
Rosiglitazone and 15-deoxy-Delta(12,14)-prostaglandin J(2), ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut 62
Adverse drug events in emergency department population: a prospective Italian study 61
Erythropoietin prevents cognition impairment induced by transient brain ischemia in gerbils 61
Beneficial effects of tempol, a membrane-permeable radical scavenger, on the multiple organ failure induced by zymosan in the rat 61
GPI 6150, a PARP inhibitor, reduces the colon injury caused by dinitrobenzene sulfonic acid in the rat 61
Effects of n-acetylcysteine in a rat model of ischemia and reperfusion injury 61
WWW.FARMACOVIGILANZA.ORG: OBIETTIVI E RISULTATI 61
Inducible nitric oxide synthase knockout mice exhibit resistance to the multiple organ failure induced by zymosan 61
Adrenocorticotropin reverses vascular dysfunction and protects against splanchnic artery occlusion shock 61
“Prescribing pattern of antipsychotic drugs in Italy: a population based study in the the years 2000-2005” 60
Protective effects of melatonin in ischemic brain injury 60
Beneficial effects of GPI 6150, an inhibitor of poly(ADP-ribose) polymerase in a rat model of splanchnic artery occlusion and reperfusion 60
A COMMUNITY PHARMACIES SURVEY ON PREVALENCE OF CONSTIPATION AND RISK FACTORS FOR LAXATIVE USE IN THE LOCAL HEALTH DISTRICTS OF VERBANIA AND MESSINA 60
5-lipoxygenase knockout mice exhibit a resistance to splanchnic artery occlusion shock 60
Endotoxin tolerance impairs a pertussis-toxin-sensitive G- protein regulating tumour necrosis factor release by macrophages from tumour-bearing rats 60
EFFECTS OF PDRN ON SPERMATOGENETIC ACTIVITY DURING THE PROGRESSION OF TESTICULAR ISCHEMIA AND REPERFUSION IN RATS 60
A case of topiramate-induced epistaxis. 60
Protective effects of endotoxin tolerance in tumor bearing rats. 60
Antibiotic prescribing for dental conditions: a community-based study in southern Italy 59
Lipid-lowering drug use in Italian primary care: effects of reimbursement criteria revision 59
Antidepressant drugs: prevalence, incidence and indication of use in general practice of Southern Italy during the years 2003-2004. 59
G 619, A DUAL THROMBOXANE SYNTHASE INHIBITOR AND THROMBOXANE-A2 RECEPTOR ANTAGONIST, REDUCES MYOCARDIAL DAMAGE AND POLYMORPHONUCLEAR LEUKOCYTE ACCUMULATION FOLLOWING CORONARY- ARTERY OCCLUSION AND REPERFUSION IN RATS 59
CENTRAL DIPSOGENIC EFFECT OF SYNTHETIC RAT ATRIAL NATRIURETIC POLYPEPTIDE IN NORMOTENSIVE RATS 59
Cyclosporin-A reduces leukocyte accumulation and protects against myocardial ischaemia reperfusion injury in rats. 58
5-lipoxygenase modulates the alteration of paracellular barrier function in mice ileum during experimental colitis 58
PROTECTIVE EFFECTS OF G-619, A DUAL THROMBOXANE SYNTHASE INHIBITOR AND THROMBOXANE-A2 RECEPTOR ANTAGONIST, IN SPLANCHNIC ARTERY-OCCLUSION SHOCK 58
5-lipoxygenase knockout mice exhibit a resistance to acute pancreatitis induced by cerulein 58
TUMOR-NECROSIS-FACTOR INVOLVEMENT IN LIPOPOLYSACCHARIDE-INDUCED INHIBITION OF DRINKING IN THE RAT 58
Peroxynitrate-mediated DNA strand breakage activates poly(ADP-ribose) synthetase and causes cellular energy depletion in a nonseptic shock model induced by zymosan in the rat 58
PROTECTIVE EFFECT OF CLORICROMENE, A COUMARINE DERIVATIVE, IN HYPOVOLEMIC HEMORRHAGIC-SHOCK IN THE RAT 57
Effect of sulfatide on acute lung injury during endotoxemia in rats 57
Crucial role of nuclear factor-kappa B in neointimal hyperplasia of the mouse carotid artery after interruption of blood flow 57
Effects of Soy Isoflavone Genistein Aglycone On Skin Changes Induced By Experimental Menopause : A Comparison With Estradiol And Raloxifene 57
Hemorrhagic cystitis induced by an herbal mixture 57
FLAVOCOXID, A DUAL INHIBITOR OF COX-2 AND 5-LOX, REDUCES PANCREATIC DAMAGE IN AN EXPERIMENTAL MODEL OF ACUTE PANCREATITIS. 57
Drug safety in children. All that paediatric clinical trials cannot do. 57
Evidence-Based Knowledge Management: an approach to effectively promote good health-care decision-making in the Information Era. 56
BENEFICIAL EFFECTS OF 5-AMINOISOQUINOLINONE, A NOVEL, POTENT,WATER-SOLUBLE, INHIBITOR OF THE OF POLY (ADP-RIBOSE) POLYMERASE, IN A RAT MODEL OF SPLANCHNIC ARTERY OCCLUSION AND REPERFUSION 56
Prescribing pattern of drugs in the treatment of osteoarthritis before and after rofecoxib withdrawal in general practice of Southern Italy 56
BENEFICIAL-EFFECTS OF BAY U3405, A NOVEL THROMBOXANE A(2) RECEPTOR ANTAGONIST, IN SPLANCHNIC ARTERY-OCCLUSION SHOCK 56
ANTIHYPERTENSIVE ACTIVITY OF INDOLEPYRUVIC ACID - A KETO ANALOG OF TRYPTOPHAN 56
5-Lipoxygenase modulates colitis through the regulation of adhesion molecule expression and neutrophil migration 56
Oral anticoagulant therapy in Italy: prescribing prevalence and clinical reasons 55
Calpain inhibitor I reduces intestinal ischemia-reperfusion injury in the rat 55
Beneficial effects of GW274150, a novel, potent and selective inhibitor of iNOS activity, in a rodent model of collagen- induced arthritis 55
Beneficial effects of 5-aminoisoquinolinone, a novel, potent, water-soluble, inhibitor of poly (ADP-ribose) polymerase, in a rat model of splanchnic artery occlusion and reperfusion 55
Totale 6.398
Categoria #
all - tutte 78.987
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.987


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201919 0 0 0 0 0 0 0 0 0 0 10 9
2019/20204.437 925 425 4 395 21 440 568 537 51 418 622 31
2020/20213.165 478 14 903 124 84 440 11 429 28 299 238 117
2021/20223.030 37 524 63 45 146 18 149 117 35 439 481 976
2022/20237.914 646 506 295 679 728 793 75 537 3.177 37 312 129
2023/20241.510 164 326 158 212 145 284 39 90 0 86 6 0
Totale 22.564